Inhibition of biliary glutathione secretion by cyclosporine A in the rat: Possible mechanisms and role in the cholestasis induced by the drug

Journal of Hepatology

Volumn 29, Issue 1, 1998, Pages 68-77

  Morán, Dominica ^a   González De Buitrago, José M ^a   Fernández, Emilio ^a   Galán, Ana I ^a   Eugenia Munoz M ^a   Jiménez, Rafael ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Bile acid dependent and independent bile flow; Bile flow; Cholestasis; Cyclosporine A; Glutathione; Glutathione dependent and independent bile flow

Indexed keywords

CYCLOSPORIN A; GLUTATHIONE;

ANIMAL EXPERIMENT; ARTICLE; BILE FLOW; BILE SECRETION; CHOLESTASIS; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG MECHANISM; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

EID: 0032125182     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80180-3     Document Type: Article

References (57)

1. Galán AI, Fernández E, Morán D, Muñoz ME, Jiménez R. Cyclosporine A hepatotoxicity: effect of prolonged treatment with cyclosporine on biliary lipid secretion in the rat. Clin Exp Pharmacol Physiol. 22:1995;260-265.
2. Román ID, Monte MJ, González-Buitrago JM, Esteller A, Jiménez R. Inhibition of hepatocytary vesicular transport by cyclosporin A in the rat: relationship with cholestasis and hyperbilirubinemia. Hepatology. 12:1990;83-91.
3. Stone BG, Udani M, Sanghyi A, Warty V, Plocki K, Bedetti CD, et al. Cyclosporin A-induced cholestasis. The mechanism in a rat model. Gastroenterology. 93:1987;344-351.
4. Debruyne D, Samba D, Lacotte J, Tartiere J, Deshayes JP, Segol PH, et al. Bile and blood ratios of cyclosporin and its metabolites in patients on continuous infusion during the first three weeks after liver transplantation. Clin Drug Invest. 12:1996;67-79.
5. Friman S, Persson H, Karlberg I, Svanvik J. The bile acid independent flow is reduced in the transplanted liver. Transplant Proc. 24:1992;396-397.
6. Sauer P, Klöters-Plachky P, Stiehl A. Inhibition of ileal bile acid transport by cyclosporin A in rat. Eur J Clin Invest. 25:1995;677-682.
7. Fernández E, Galán AI, Morán D, González-Buitrago JM, Muñoz ME, Jiménez R. Reversal of cyclosporine A-induced alterations in biliary secretion by S-adenosyl-L-methionine in rats. J Pharmacol Exp Ther. 275:1995;442-449.
8. Stacey N, Kotecka B. Inhibition of taurocholate and ouabain transport in isolated rat hepatocytes by cyclosporin A. Gastroenterology. 95:1988;780-786.
9. Galán AI, Román ID, Muñoz ME, Cava F, González-Buitrago JM, Jiménez R. Inhibition of biliary lipid and protein secretion by cyclosporine A in the rat. Biochem Pharmacol. 44:1992;1105-1113.
10. Böhme M, Müller M, Leier I, Jedlitschky G, Keppler D. Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver. Gastroenterology. 107:1994;255-265.
11. Kadmon M, Klünemann C, Böhme M, Ishikawa T, Gorgas K, Otto G, et al. Inhibition by cyclosporin A of adenosine triphosphate-dependent transport from the hepatocyte into bile. Gastroenterology. 104:1993;1507-1514.
12. Böhme M, Büchler M, Müller M, Keppler D. Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane. FEBS Lett. 333:1993;193-196.
13. Boyer JL. Bile secretion-models, mechanisms, and malfunctions. A perspective on the development of modern cellular and molecular concepts of bile secretion and cholestasis. J Gastroenterol. 31:1996;475-481.
14. Ballatori N, Truong AT. Relation between biliary glutathione excretion and bile acid-independent bile flow. Am J Physiol. 256:1989;G22-G30.
15. Lauterburg BH. Biliary excretion of glutathione and glutathione adducts. Prog Pharmacol Clin Pharmacol. 8:1991;201-213.
16. Bouchard G, Yousef IM, Tuchweber B. Decreased biliary glutathione content is responsible for the decline in bile salt-independent flow induced by ethinyl estradiol in rats. Toxicol Lett. 74:1994;221-233.
17. Deleve LD, Kaplowitz N. Importance and regulation of hepatic glutathione. Semin Liver Dis. 10:1990;251-266.
18. Ballatori N, Dutczak WJ. Identification and characterization of high and low affinity transport systems for reduced glutathione in liver cell canalicular membranes. J Biol Chem. 269:1994;19731-19737.
19. Fernández-Checa JC, Takikawa H, Horie T, Ookhtens M, Kaplowitz N. Canalicular transport of reduced glutathione in normal and mutant Eisai hyperbilirubinemic rats. J Biol Chem. 267:1992;1667-1673.
20. Fernández-Checa JC, Yi JR, García-Ruiz C, Ookhtens M, Kaplowitz N. Plasma membrane and mitochondrial transport of hepatic reduced glutathione. Semin Liv Dis. 16:1996;147-158.
21. Keppler D, Arias IM. Hepatic canalicular membrane. Introduction: transport across the hepatocyte canalicular membrane. FASEB J. 11:1997;15-18.
22. Lu SC, Sun WM, Yi J, Ookhtens M, Sze G, Kaplowitz N. Role of two recently cloned rat liver GSH transporters in the ubiquitous transport of GSH in mammalian cells. J Clin Invest. 97:1996;1488-1496.
23. Müller M, Roelofsen H, Jansen PLM. Secretion of organic anions by hepatocytes: involvement of homologues of the multidrug resistence protein. Semin Liver Dis. 16:1996;211-220.
24. Oude Elferink RPJ, Meijer DKF, Kuipers F, Jansen PLM, Groen AK, Groothuis GMM. Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. Biochim Biophys Acta. 1241:1995;215-268.
25. Paulusma CC, Van Geer M, Heijn M, Evers R, Ottenhoff R, Oude Elferink RPJ. The canalicular multispecific organic anions transporter mediates transport of reduced glutathione. [abstract] Hepatology. 26:1997;292.
26. Tamai I, Safa AR. Competitive interaction of cyclosporins with the vinca alkaloid-binding site of P-glycoprotein in multidrug-resistant cells. J Biol Chem. 265:1990;16509-16513.
27. Speeg KW, Maldonado AL, Liaci J, Muirhead D. Effect of cyclosporine on colchicine secretion by a liver canalicular transporter studied in vivo. Hepatology. 15:1992;899-903.
28. Hagmann W, Parthé S, Kaiser I. Uptake, production and metabolism of cysteinyl leukotrienes in the isolated perfused rat liver. Inhibition of leukotriene uptake by cyclosporine. Biochem J. 261:1989;611-616.
29. Moseley RH, Johnson TR, Morrissette JM. Inhibition of bile acid transport by cyclosporine A in rat liver plasma membrane vesicles. J Pharmacol Exp Ther. 253:1990;974-980.
30. Kukongviriyapan U, Stacey NH. Inhibition of taurocholate transport by cyclosporin A in cultured rat hepatocytes. J Pharmacol Exp Ther. 247:1988;685-689.
31. Romanelli R, Che M, Leveille C, Gatmaitan Z, Arias IM. Effect of cholestatic compounds on bile canalicular ATP-dependent and membrane potential-dependent transport system. [abstract] Hepatology. 18:1993;139.
32. Foxwell BMJ, Mazkie A, Ling V, Ryffel B. Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein. Mol Pharmacol. 36:1989;543-546.
33. Saeki T, Ueda K, Tanigawa Y, Hori R, Komano T. Human P-glycoprotein transports cyclosporin A and FK 506. J Biol Chem. 268:1993;6077-6080.
34. Ballatori N, Jacob R, Boyer JL. Intrabiliary glutathione hydrolysis. A source of glutamate in bile. J Biol Chem. 261:1986;7860-7865.
35. Edkins RD, Rybak LP, Hoffman DW. Comparison of cyclosporine and FK506 effects on glutathione levels in rat cochlea, brain, liver and kidney. Biochem Pharmacol. 43:1992;911-913.
36. Mueller K, Siems WG, Grune T, David H, Henke W, Jung K. Adaptational increase of liver glutathione content during long-term application of cyclosporine A may attenuate toxic side effects. Cell Mol Biol. 38:1992;729-738.
37. Duruibe VA, Okonmah A, Blyden GT. Effect of cyclosporine A on rat liver and kidney glutathione content. Pharmacology. 39:1989;205-212.
38. Morán D, Galán AI, Fernández E, Moreno C, Jiménez R, Muñoz ME. Changes in glutathione hepatic content and γ-glutamyl-cycle enzymes during CyA long term treatment in the rat. [abstract] J Hepatol. 23:1995;160. (Suppl. 1).
39. Griffith Ow. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem. 106:1980;207-212.
40. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27:1969;502-522.
41. Adams JD, Lauterburg BH, Mitchell JR. Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. J Pharmacol Exp Ther. 227:1983;749-754.
42. Lindgren BW. Statistical Theory. 1976;542-545 McMillan, New York.
43. Fernández E, González-Buitrago JM, Navajo JA, Galán AI, Moreno C, Muñoz ME, et al. Interrelationship between hepatic, renal and pancreatic cyclosporine A-induced toxicity and its evolution with time in the rat. Recent Res Devel Antimicrob Agents Chemother. 1:1996;181-189.
44. Al-Khader A, Al-Sulaiman M, Kishore PN, Morais C, Tariq M. Quinacrine attenuates cyclosporine induced nephrotoxicity in rats. Transplantation. 62:1996;427-435.
45. Wolf A, Trendelenburg C, Aicher L, Schramm U, Fahr A, Fricker G. Interactions of cyclosporin A and its derivative IMM-125 with rat hepatocytes. [abstract] Hepatology. 22:1995;382.
46. Bäckman L, Appelkvist EL, Dallner G. Influence of cyclosporine A on protein synthesis in rat liver. Exp Mol Pathol. 49:1988;38-49.
47. Ziegler K, Polzin G, Frimmer M. Hepatocellular uptake of cyclosporin A by simple diffusion. Biochim Biophys Acta. 938:1988;44-50.
48. Whitington PF, Dudeja P, Hecht JR, Whitington SH, Brasitus TA. Lipid alterations in the hepatocyte basolateral sinusoidal membrane (BLM) domain may explain cyclosporine (CsA) induced cholestasis in the rat. [abstract] Hepatology. 8:1988;1363.
49. Böhme M, Jedlitschky G, Leier I, Büchler M, Keppler D. ATP-dependent export pumps and their inhibition by cyclosporins. Adv Enzym Reg. 34:1994;371-380.
50. Keppler D, König J. Hepatic canalicular membrane 5: expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB J. 11:1997;509-516.
51. Büchler M, König J, Brom M, Kartenbeck J, Spring H, Horie T, et al. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem. 271:1996;15091-15098.
52. Galán AI, Zapata AJ, Román ID, Muñoz ME, González J, Jiménez R. Impairment of maximal bilirubin secretion by cyclosporin A in the rat. Arch Int Physiol Biochim Biophys. 99:1991;373-376.
53. Ruiz J, Galán AI, Muñoz ME, Moreno C, González-Buitrago JM, Morán D, et al. Reversal of cyclosporine-induced impairments on hepatic handling of BSP and DBSP in the rat by S-adenosyl-L-methionine. [abstract] J Hepatol. 23:1995;159. (Suppl. 1).
54. Lu SC, Kuhlenkamp J, Wu H, Sun WM, Stone L, Kaplowitz N. Progressive defect in biliary GSH secretion in streptozotocin-induced diabetic rats. Am J Physiol. 272:1997;G374-G382.
55. Fernández-Checa JC, Ookhtens M, Kaplowitz N. Selective induction by phenobarbital of electrogenic transport of glutathione and organic anions in rat liver canalicular membrane vesicles. J Biol Chem. 268:1993;10836-10841.
56. Zaman GR, Lankelma J, Van Tellingen O, Beijnen J, Dekker H, Paulusma C, et al. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA. 92:1995;7690-7694.
57. Fardel O, Ratanasavanh D, Loyer P, Ketterer B, Guillouzo A. Over-expression of the multidrug-resistance gene product in adult rat hepatocytes during primary culture. Eur J Biochem. 205:1992;847-852.